October 19, 2020 Clinical Research/Diagn. Life Science Tools Product Launch

Bio-Techne Announces Commercial Release of New SARS-CoV-2 Multi-antigen Serology Assay Kit for Simple Western

New serology assay accelerates COVID-19 research and vaccine development through rapid characterization of human immune response to multiple SARS-CoV-2 antigens MINNEAPOLIS, Oct. 19, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that ProteinSimple, a Bio-Techne brand, released its SARS-CoV-2 Multi-Antigen Serology Module for Jess and Wes Simple Western automated western blotting systems.  The SARS-CoV-2 multi-antigen... Read more

October 14, 2020 Clinical Research/Diagn. Lab Top-10

PerkinElmer and BioMarin Collaborate to Enable Diagnostic Testing for Rare Diseases in Mexico

Opening of new diagnostic lab expands access to no charge diagnostic genetic testing forBatten disease and Mucopolysaccharidosis disorders WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that BioMarin has selected the Company to provide testing support for its Sponsored Testing Program for patients in Mexico. BioMarin is a... Read more

October 12, 2020 Acad, Gov/Utilities Clinical Research/Diagn. Microscopy PR/Corporate

GE Healthcare Receives FDA Clearance for Vivid Ultra Edition, AI-Powered Cardiovascular Ultrasound System Designed to Shorten Diagnostic Exam Time and Improve Measurement Consistency

Chicago (October 12, 2020) – GE Healthcare today announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid[1] cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently. Methodical assessments of heart function are key in echocardiography but can be tedious... Read more

October 8, 2020 Clinical Research/Diagn. Life Science Tools

Fluidigm to Offer Millions of Advanta COVID-19 Tests at Low Cost to U.S. Colleges and Universities

Fluidigm COVID-19 Campus Safeguard Program Improves Availability of Noninvasive, Saliva-Based SARS-CoV-2 Tests for Higher Education Institutions High-Throughput, Integrated Testing Platform and Reliable Supply Chain SOUTH SAN FRANCISCO, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a program to expand availability of Fluidigm® COVID-19 tests for U.S. colleges and universities. The Fluidigm COVID-19 Campus Safeguard Program will provide... Read more

September 30, 2020 Atomic Spectroscopy Bio/Pharma/CRO Clinical Research/Diagn. Environ, Ag./Food & Bev Informatics & Software Lab Top-10 PAI Top-10

PerkinElmer Signals Notebook and PerkinElmer Signals Medical Review Cloud-Based Software Gain SOC 2 Attestation for Biopharmaceutical Research and Clinical Trial Data

Company’s Informatics Solutions Meet AICPA’s Trust Service Principles for Security, Confidentiality & Availability WALTHAM, Mass. –  September 30, 2020  –  PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that the PerkinElmer Signals™ Notebook and PerkinElmer Signals™ Medical Review SaaS solutions have been granted SOC 2 Level 1 Attestation for... Read more

September 29, 2020 Atomic Spectroscopy Clinical Research/Diagn.

GE Healthcare to collaborate with French SMEs, start-ups, research labs and clinical centers to help accelerate AI development in imaging

Buc, France – September 29, 2020 – GE Healthcare announces the launch of the AI DReAM project, a consortium that gathers French SMEs, start-ups, research labs and clinical centers to facilitate the development of AI in medical imaging. Supported with €13 million by the “Investments for the Future” program (PIA), led by the French General... Read more

September 25, 2020 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Zymo Research Granted CE IVD Mark for Sample Collection Devices

SAFE AND RELIABLE SAMPLE PRESERVATION AT AMBIENT TEMPERATURE FOR IVD APPLICATIONS Zymo Research was granted the CE IVD mark for its DNA/RNA Shield™ reagent and collection devices. IRVINE, Calif., (Sept. 25, 2020) — Zymo Research announced that three of its DNA/RNA Shield™ collection devices: 1) DNA/RNA Shield™ collection tube w/ swab, 2) DNA/RNA Shield™ Saliva/Sputum Collection Kit, and 3) DNA/RNA Shield™ Fecal Collection... Read more

September 24, 2020 Clinical Research/Diagn. Informatics & Software Licensing, IP, and Legal

Clear Labs Granted EUA by FDA for SARS-CoV-2 Novel Descriptive Diagnostic

NGS-enabled platform tracks infection clusters for contact tracing and monitors emerging mutations, combining once separate aspects of screening and genomic surveillance SAN CARLOS, CALIF. (PRWEB) SEPTEMBER 24, 2020 Clear Labs, providers of the only fully automated and intelligent next-generation sequencing (NGS) in vitro diagnostic (IVD) platform, today announced that the U.S. Food and Drug Administration (FDA) has... Read more

September 23, 2020 Atomic Spectroscopy Clinical Research/Diagn. Lab Top-10

Thermo Fisher Scientific Introduces Oncomine Clinical Research Grant Program to Support Oncology and Reproductive Health Studies

Thermo Fisher Scientific Introduces Oncomine Clinical Research Grant Program to Support Oncology and Reproductive Health Studies CARLSBAD, Calif., Sept. 23, 2020 /PRNewswire/ — Thermo Fisher Scientific today introduced the Oncomine Clinical Research Grant Program to support clinical research projects in oncology and reproductive health. The program aims to provide support for high-quality molecular profiling studies... Read more

September 18, 2020 Bio/Pharma/CRO Clinical Research/Diagn. Microscopy

Roche’s phase III EMPACTA study showed Actemra/RoActemra reduced the likelihood of needing mechanical ventilation in hospitalised patients with COVID-19 associated pneumonia

EMPACTA is the first global phase III trial to show efficacy with Actemra/RoActemra in COVID-19 associated pneumonia and the first with a focus on enrolling largely underserved and minority patients There was no statistical difference in mortality between patients who received Actemra/RoActemra or placebo Roche plans to share these results with health authorities, including the... Read more